Drugs / Tongmai Yangxin Pill
Tongmai Yangxin Pill
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05008250 | Jan 2014 → Aug 2015 | cardiac rhythm disease | Xuanwu Hospital, Beijing | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tongmai Yangxin Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05008250 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “TMYXP is a Chinese patent medicine developed by many years of clinical practice experience.” NCT05008250 ↗ |
| Route | Oral | “40 pills twice per day, orally” NCT05008250 ↗ |